Voxelotor: alteration of sickle cell disease pathophysiology by a first-in-class polymerization inhibitor

por Glaros, Alexander K., Razvi, Reza, Shah, Nirmish, Zaidi, Ahmar U.
Publicado 2021

Targeting TRPV1 activity via high‐dose capsaicin in patients with sickle cell disease

por Glaros, Alexander K., Callaghan, Michael U., Smith, Wally R., Zaidi, Ahmar U.
Publicado 2022

Flow adhesion of whole blood to P‐selectin: a prognostic biomarker for vaso‐occlusive crisis in sickle cell disease

por Hines, Patrick C., Callaghan, Michael U., Zaidi, Ahmar U., Gao, Xiufeng, Liu, Ke, White, Jennell, Tarasev, Michael
Publicado 2021

A systematic literature review of frequency of vaso-occlusive crises in sickle cell disease

por Zaidi, Ahmar U., Glaros, Alexander K., Lee, Soyon, Wang, Taiji, Bhojwani, Rhea, Morris, Eric, Donohue, Breanne, Paulose, Jincy, Iorga, Şerban R., Nellesen, Dave
Publicado 2021

Clinical predictors of poor outcomes in patients with sickle cell disease and COVID-19 infection

por Minniti, Caterina P., Zaidi, Ahmar U., Nouraie, Mehdi, Manwani, Deepa, Crouch, Gary D., Crouch, Andrew S., Callaghan, Michael U., Carpenter, Sarah, Jacobs, Charleen, Han, Jin, Simon, Jena, Glassberg, Jeffrey, Gordeuk, Victor R., Klings, Elizabeth S.
Publicado 2021